InMed Pharmaceuticals Inc...

3.28
-0.23 (-6.55%)
At close: Jan 30, 2025, 3:59 PM
3.27
-0.30%
After-hours Jan 30, 2025, 04:00 PM EST

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10 FY09 FY08 FY07 FY06 FY05 FY04 FY03 FY02 FY01
Net Income -7.68M -7.95M -18.60M -10.20M -8.68M -10.10M -6.71M -3.44M -1.84M -3.46M -1.15M -46.74K -189.92K -325.47K -334.79K -1.06M -922.26K -1.87M -1.27M -2.78M -1.52M -1.23M -2.71M -4.27M
Depreciation & Amortization 604.52K 596.00K 511.79K 120.87K 161.97K 94.72K -92.78K 75.22K 67.41K 75.76K 40.30 n/a n/a 135.52K 69.50K 168.76K 83.24K 169.63K 252.49K 426.34K 295.85K 380.70K 1.85M 2.22M
Stock-Based Compensation 137.71K 278.15K 697.89K 610.19K 994.40K 3.11M 2.43M 1.17M 695.20K 1.69M 666.83K n/a n/a n/a n/a 95.81K n/a n/a n/a n/a n/a n/a n/a n/a
Other Working Capital -435.56K 16.17K -687.51K -490.65K 334.32K 307.97K 426.85K n/a n/a n/a n/a n/a 14.70K n/a n/a 219.66K 92.08K 233.98K 119.40K 290.81K 240.13K 116.05K n/a n/a
Other Non-Cash Items 316.82K -803 4.46M 374.23K 18.62K -71.39K 2.51M 0.00 0.00 -0.00 0.00 n/a n/a n/a -0.00 514.84K -215.03K 85.28K 322.38K 1.34M 394.10K -543.33 -3.12K 927.28K
Deferred Income Tax n/a 356.89K n/a -242.39K 80.85K 1.92 -2.25M n/a n/a n/a n/a n/a n/a n/a n/a 0.00 n/a n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital -369.34K -565.82K -2.73M -450.45K 351.30K 283.89K 431.40K -165.80K 688.73K 87.91K -156.08K 7.48K 15.30K -372.10K 69.87K 380.91K 102.90K 223.99K 120.27K 309.79K 345.72K 5.62K -274.51K 653.32K
Operating Cash Flow -6.99M -7.28M -15.58M -9.79M -7.15M -6.68M -3.68M -2.37M -386.07K -1.61M -641.38K -39.26K -174.62K -562.06K -195.42K 100.48K -951.15K -1.40M -577.40K -702.23K -484.19K -844.62K -1.14M -471.69K
Capital Expenditures -9.29K -161.80K -39.11K -1.73K -41.85K -27.03K -43.80K -19.52K -885 -4.84K -2.03K n/a n/a n/a n/a n/a -24.85K -12.52K n/a -7.31K -15.45K -24.62K -12.64K -764.02K
Acquisitions n/a -500.00K -208.89K n/a 541.00 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -123.22K n/a n/a -285.70K n/a n/a n/a n/a
Purchase of Investments -42.08K -42.27K -425.00K n/a -42.10K -2.06M -1.83M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -1.08M
Sales Maturities Of Investments 42.08K 42.27K 425.00K n/a 3.70M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 386.16K n/a n/a n/a 33.82K 702.49K 1.42M n/a
Other Investing Acitivies -9.29K -501.79K -425.00K 0.00 -9.01 -17.03K 0.00 n/a n/a n/a n/a n/a n/a n/a n/a n/a -0.00 2.11K n/a -78.61K -0.00 -361.16K -303.73K 37.90K
Investing Cash Flow -9.29K -661.80K -673.00K -1.73K 3.62M -2.11M -1.88M -19.52K -885 -4.84K -2.03K n/a n/a n/a n/a n/a 238.09K -10.41K n/a -371.63K 18.38K 316.70K 1.11M -1.81M
Debt Repayment n/a n/a -290.83K n/a -71.30K n/a n/a n/a n/a n/a n/a n/a n/a 11.70K 33.68K -146.67K 14.62K 226.04K -37.65K -129.23K -65.64K n/a n/a -40.21K
Common Stock Repurchased n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -58.50K
Dividend Paid n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies 175.00 646.00 -1.78M -1.62M 40.30K 64.93K -1.02M -764.62K -4.54K -92.75K -297 n/a n/a n/a n/a -0.00 -153.40K -89.88K -14.22K 27.09K 30.25K 554.07K n/a -0.47
Financial Cash Flow 4.65M 10.68M 15.07M 10.85M -42.08K 272.50K 19.27M 7.50M 300.14K 1.74M 646.44K n/a n/a 792.58K 195.42K -141.50K 626.21K 1.48M 648.18K 1.04M 428.40K 572.97K n/a 2.21M
Net Cash Flow -2.34M 2.74M -1.19M 1.56M -3.63M -8.58M 13.25M 5.12M -86.82K 128.07K 3.03K -39.26K -174.62K 230.53K -0.89 -41.02K -86.86K 78.27K 70.77K -37.00K -37.42K 45.06K -36.03K -68.31K
Free Cash Flow -7.00M -7.45M -15.62M -9.79M -7.19M -6.71M -3.72M -2.38M -386.96K -1.61M -643.42K -39.26K -174.62K -562.06K -195.42K 100.48K -976.01K -1.41M -577.40K -709.54K -499.64K -869.23K -1.16M -1.24M